Bacterial Chassis Cofactor Engineering Patents: Leaders & Gaps 2026
Bacterial chassis cofactor engineering patents: who holds the redox balance claims
34.8% concentration at the top. The five leading assignees account for 64 of 184 records in scope, while the ranked list runs 85 companies deep with a long single-filing tail below them. Filings rose from 5 in 2017 to a peak of 25 in 2020, dipped, then climbed again from 7 in 2021 to 12 in 2024 — a 71% increase over that span. 2025 and 2026 figures are still filling in due to publication lag and should not be read as a decline.
- 1GENENTECH INC20
- 2SYNLOGIC OPERATING CO INC13
- 3MANUS BIO INC12
- 4NOVOZYMES AS10
- 5DEINOVE SA9
See the full bacterial chassis cofactor engineering analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on bacterial chassis cofactor engineering patents
What counts as a bacterial chassis cofactor engineering patent?
It is a filing on an engineered or recombinant bacterial host where the claimed invention specifically manipulates cofactor dynamics — NADH/NADPH balance, redox ratio, cofactor recycling, electron transfer, or cellular energy charge — rather than bacterial engineering in general. In this dataset that scope is defined by combining host-cell and cofactor-related search terms with IPC classes for genetic engineering (C12N15/09), microorganism handling (C12N1/20) and enzyme/DNA measurement (C12Q1/68). A strain patent that only mentions yield improvement without a cofactor-specific mechanism would fall outside this scope.
Who are the leading patent filers in bacterial chassis cofactor engineering?
The ranked list covers 85 assignees, with the top-ranked filer holding 20 records against 9 for the fifth-place assignee and 6 for tenth place. Filers span large industrial and pharmaceutical companies alongside universities and research institutes, and the top five combined account for 34.8% of all 184 records in scope. Below the top ten, most assignees hold only a handful of families each, so the field is concentrated at the top but not dominated by any single company.
Is patent filing in this field growing or slowing down?
Filings grew from 7 in 2021 to 12 in 2024, a 71% increase, after an earlier peak of 25 in 2020. Because patent publication typically lags filing by around 18 months, the lower counts visible in 2025 and 2026 reflect that lag rather than an actual slowdown. Reading the 2021–2024 window is the more reliable way to judge current momentum.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Bacterial Chassis Cofactor Engineering covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.